ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Rapport Therapeutics, Inc.
27.28
+0.1900
0.70%
成交量:
18.71万
成交额:
503.57万
市值:
13.00亿
市盈率:
-10.04
高:
27.31
开:
26.70
低:
25.78
收:
27.09
52周最高:
42.27
52周最低:
6.43
股本:
4,766.11万
流通股本:
2,656.72万
量比:
0.75
换手率:
0.70%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.7168
每股收益(LYR):
-3.7760
净资产收益率:
-23.41%
总资产收益率:
-15.89%
市净率:
2.54
市盈率(LYR):
-7.22
数据加载中...
总览
公司
新闻资讯
公告
Rapport Therapeutics计划于2027年上半年启动RAP-219治疗PGTCs的三期临床试验
美股速递
·
01/07
BUZZ--美国股票走势-星座能源、威廉姆斯-索诺玛
路透中文
·
2025/11/19
BUZZ--美国股票走势-Lowe's, TJX Companies, Target
路透中文
·
2025/11/19
BUZZ--美国股票走势-Lowe's, TJX Companies, Target
路透中文
·
2025/11/19
BUZZ-BTIG 转而看好生物技术行业,认为 2026 年将是 "辉煌的一年
路透中文
·
2025/11/19
美国研究综述-安进、Crowdstrike、美光科技
路透中文
·
2025/11/19
Rapport Therapeutics:Rap-219 第二阶段临床试验进展顺利,预计2027年上半年公布主要结果
美股速递
·
2025/11/06
生物科技股复苏:四大因素推动行业上涨
金十数据
·
2025/11/04
美国研究综述-Chewy、Phillips 66、Vimeo
路透中文
·
2025/09/11
美国研究综述-Chewy、Phillips 66、Vimeo
路透中文
·
2025/09/11
美股周三早盘专注于中枢神经系统(CNS)疾病创新疗法研发的生物制药公司Rapport Therapeutics股价重挫此
智通财经
·
2025/09/10
生物制药公司Rapport重挫18.8%,此前完成2.5亿美元的公开发行
环球市场播报
·
2025/09/10
BUZZ-Rapport Therapeutics 募资 2.5 亿美元后业绩下滑
路透中文
·
2025/09/10
Rapport Therapeutics Inc.按每股26.00美元价格公开发行960万股普通股
美股速递
·
2025/09/10
美国研究综述-IQVIA Holdings、Reliance、United Therapeutics
路透中文
·
2025/09/09
Pmv Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报1.39美元
市场透视
·
2025/09/08
异动解读 | 癫痫药物临床试验成功,Rapport Therapeutics盘前大涨171.59%
异动解读
·
2025/09/08
Rapport Therapeutics公布局灶性癫痫发作试验积极结果
投资观察
·
2025/09/08
BUZZ-癫痫药物在中期试验中达到主要目标,Rapport Therapeutics 公司业绩大涨
路透中文
·
2025/09/08
Rapport Therapeutics股价盘前大涨75.5%,局灶性癫痫发作治疗药物中期试验数据表现积极
美股速递
·
2025/09/08
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/RAPP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":27.28,"timestamp":1770670800000,"preClose":27.09,"halted":0,"volume":187056,"delay":0,"changeRate":0.007013658176448921,"floatShares":26567199,"shares":47661138,"eps":-2.716762,"marketStatus":"盘前交易","change":0.19,"latestTime":"02-10 07:33:20 EST","open":26.7,"high":27.31,"low":25.78,"amount":5035657.134816,"amplitude":0.056478,"askPrice":29.71,"askSize":100,"bidPrice":27.28,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.716762,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":27.28,"postHourTrading":{"tag":"盘后","latestPrice":27.28,"preClose":27.28,"latestTime":"16:49 EST","volume":10200,"amount":278254.38,"timestamp":1770673796450,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7451521847824832,"impliedVol":0.6932,"impliedVolPercentile":0.316},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":26567199,"roa":"-15.89%","roe":"-23.41%","lyrEps":-3.775953,"volumeRatio":0.7451521847824832,"shares":47661138,"dividePrice":0,"high":27.31,"amplitude":0.056478,"preClose":27.09,"low":25.78,"week52Low":6.43,"pbRate":"2.54","week52High":42.2685,"institutionHeld":0,"latestPrice":27.28,"committee":-0.960784,"eps":-2.716762,"divideRate":0,"volume":187056,"delay":0,"ttmEps":-2.716762,"open":26.7,"prevYearClose":30.34,"prevWeekClose":27.09,"prevMonthClose":26.61,"prevQuarterClose":30.34,"fiveDayClose":27.75,"twentyDayClose":28.96,"sixtyDayClose":25.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"RAPP","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-08-07","symbol":"RAPP","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2025-05-08","symbol":"RAPP","fiscalQuarterEnding":"2025/03","expectedEps":-0.77,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2024-11-07","symbol":"RAPP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"盘前","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1763701200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2026-02-06","current":-10.041365,"percent":0.381862,"low":-19.654107,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"high":-3.640031,"avg":-10.348757,"sd":4.103842,"marketCap":1217742075},"quantilePoints":[{"date":"2024-06-07","current":-14.341434,"twenty":-13.293406,"median":-11.721364,"eighty":-11.721364,"marketCap":735830305},{"date":"2024-06-14","current":-17.322989,"twenty":-16.966549,"median":-15.024031,"eighty":-12.769392,"marketCap":888807905},{"date":"2024-06-21","current":-15.733266,"twenty":-17.881887,"median":-15.772475,"eighty":-14.348329,"marketCap":807242405},{"date":"2024-06-28","current":-16.581593,"twenty":-17.17471,"median":-16.18238,"eighty":-14.635158,"marketCap":850768389},{"date":"2024-07-05","current":-17.059223,"twenty":-17.829134,"median":-16.431888,"eighty":-15.672154,"marketCap":875274616},{"date":"2024-07-12","current":-18.299635,"twenty":-18.057796,"median":-16.595851,"eighty":-15.733266,"marketCap":938917651},{"date":"2024-07-19","current":-14.343149,"twenty":-18.092899,"median":-16.610109,"eighty":-15.733266,"marketCap":735918314},{"date":"2024-07-26","current":-16.431888,"twenty":-18.057796,"median":-16.50674,"eighty":-14.592658,"marketCap":843087333},{"date":"2024-08-02","current":-15.740395,"twenty":-18.021611,"median":-16.417631,"eighty":-14.614044,"marketCap":807608170},{"date":"2024-08-09","current":-11.062669,"twenty":-17.829134,"median":-16.189509,"eighty":-14.507112,"marketCap":697147270},{"date":"2024-08-16","current":-12.078391,"twenty":-17.822005,"median":-15.897228,"eighty":-14.341434,"marketCap":761156070},{"date":"2024-08-23","current":-12.943207,"twenty":-17.322989,"median":-15.776039,"eighty":-12.769083,"marketCap":815654991},{"date":"2024-08-30","current":-12.623979,"twenty":-17.301602,"median":-15.672154,"eighty":-12.252515,"marketCap":795537939},{"date":"2024-09-06","current":-11.799793,"twenty":-17.107699,"median":-14.956226,"eighty":-12.030797,"marketCap":743599370},{"date":"2024-09-13","current":-11.027844,"twenty":-17.007896,"median":-14.603351,"eighty":-11.813723,"marketCap":694952683},{"date":"2024-09-20","current":-12.322165,"twenty":-16.6871,"median":-14.421566,"eighty":-11.752199,"marketCap":776518182},{"date":"2024-09-27","current":-12.380206,"twenty":-16.587296,"median":-14.342291,"eighty":-11.752199,"marketCap":780175827},{"date":"2024-10-04","current":-12.072587,"twenty":-16.581593,"median":-13.041877,"eighty":-11.742318,"marketCap":760790305},{"date":"2024-10-11","current":-12.798103,"twenty":-16.461829,"median":-12.783593,"eighty":-11.721364,"marketCap":806510876},{"date":"2024-10-18","current":-15.061713,"twenty":-16.461829,"median":-13.041877,"eighty":-11.742318,"marketCap":949159059},{"date":"2024-10-25","current":-14.057599,"twenty":-16.431888,"median":-14.106934,"eighty":-11.752199,"marketCap":885881788},{"date":"2024-11-01","current":-14.289764,"twenty":-16.420482,"median":-14.289764,"eighty":-11.78122,"marketCap":900512371},{"date":"2024-11-08","current":-13.587752,"twenty":-16.360601,"median":-14.196898,"eighty":-11.792828,"marketCap":976225637},{"date":"2024-11-15","current":-10.665545,"twenty":-16.293733,"median":-13.709352,"eighty":-11.752199,"marketCap":766276774},{"date":"2024-11-22","current":-11.755009,"twenty":-16.213426,"median":-13.641207,"eighty":-11.719637,"marketCap":844550392},{"date":"2024-11-29","current":-11.627735,"twenty":-16.188083,"median":-13.405914,"eighty":-11.573511,"marketCap":835406277},{"date":"2024-12-06","current":-10.416089,"twenty":-16.139607,"median":-12.943207,"eighty":-11.450385,"marketCap":748354310},{"date":"2024-12-13","current":-9.555718,"twenty":-15.982774,"median":-12.73716,"eighty":-11.371152,"marketCap":686540097},{"date":"2024-12-20","current":-9.199351,"twenty":-15.858733,"median":-12.415031,"eighty":-11.254059,"marketCap":660936577},{"date":"2024-12-27","current":-9.688083,"twenty":-15.824515,"median":-12.350651,"eighty":-11.045256,"marketCap":696049976},{"date":"2025-01-03","current":-9.917175,"twenty":-15.797425,"median":-12.316361,"eighty":-10.975704,"marketCap":712509382},{"date":"2025-01-10","current":-7.539701,"twenty":-15.740395,"median":-12.304752,"eighty":-10.859002,"marketCap":541697328},{"date":"2025-01-17","current":-6.460419,"twenty":-15.733266,"median":-12.215086,"eighty":-10.644772,"marketCap":464155239},{"date":"2025-01-24","current":-7.076424,"twenty":-15.684376,"median":-12.087097,"eighty":-10.43238,"marketCap":508412752},{"date":"2025-01-31","current":-8.354253,"twenty":-15.597056,"median":-11.915876,"eighty":-10.137105,"marketCap":600219659},{"date":"2025-02-07","current":-8.211706,"twenty":-15.257893,"median":-11.843324,"eighty":-9.686047,"marketCap":589978251},{"date":"2025-02-14","current":-8.094614,"twenty":-15.103195,"median":-11.828814,"eighty":-9.441681,"marketCap":581565666},{"date":"2025-02-21","current":-6.455328,"twenty":-15.070846,"median":-11.799793,"eighty":-9.297098,"marketCap":463789474},{"date":"2025-02-28","current":-5.106225,"twenty":-15.037336,"median":-11.771597,"eighty":-9.077168,"marketCap":366861863},{"date":"2025-03-07","current":-4.373128,"twenty":-15.01412,"median":-11.747556,"eighty":-8.771711,"marketCap":314191765},{"date":"2025-03-14","current":-4.898381,"twenty":-14.977526,"median":-11.717047,"eighty":-8.416363,"marketCap":383577552},{"date":"2025-03-21","current":-4.530187,"twenty":-14.817535,"median":-11.627735,"eighty":-8.164869,"marketCap":354745367},{"date":"2025-03-28","current":-4.68399,"twenty":-14.676319,"median":-11.461087,"eighty":-7.790176,"marketCap":366789191},{"date":"2025-04-04","current":-4.189957,"twenty":-14.640334,"median":-11.410917,"eighty":-7.133443,"marketCap":328102968},{"date":"2025-04-11","current":-4.315796,"twenty":-14.632186,"median":-11.370643,"eighty":-6.989878,"marketCap":337957006},{"date":"2025-04-17","current":-4.730597,"twenty":-14.622599,"median":-11.327444,"eighty":-6.74653,"marketCap":370438835},{"date":"2025-04-25","current":-4.949801,"twenty":-14.60549,"median":-11.189913,"eighty":-6.457364,"marketCap":387604034},{"date":"2025-05-02","current":-5.280719,"twenty":-14.55844,"median":-11.048158,"eighty":-5.528775,"marketCap":413517298},{"date":"2025-05-09","current":-4.693792,"twenty":-14.472894,"median":-10.976093,"eighty":-5.332796,"marketCap":374099938},{"date":"2025-05-16","current":-4.560992,"twenty":-14.4176,"median":-10.940782,"eighty":-5.2164,"marketCap":363515647},{"date":"2025-05-23","current":-5.092192,"twenty":-14.397354,"median":-10.8247,"eighty":-5.097805,"marketCap":405852811},{"date":"2025-05-30","current":-3.896992,"twenty":-14.370288,"median":-10.665545,"eighty":-4.981023,"marketCap":310594193},{"date":"2025-06-06","current":-5.646289,"twenty":-14.346875,"median":-10.527934,"eighty":-4.950803,"marketCap":450014853},{"date":"2025-06-13","current":-5.101351,"twenty":-14.342806,"median":-10.416089,"eighty":-4.981023,"marketCap":406582762},{"date":"2025-06-20","current":-5.050978,"twenty":-14.341434,"median":-10.309179,"eighty":-5.014344,"marketCap":402568031},{"date":"2025-06-27","current":-5.408165,"twenty":-14.289764,"median":-9.866266,"eighty":-5.000606,"marketCap":431036124},{"date":"2025-07-03","current":-5.513507,"twenty":-14.247974,"median":-9.698265,"eighty":-5.011596,"marketCap":439432031},{"date":"2025-07-11","current":-7.043002,"twenty":-14.172521,"median":-9.586263,"eighty":-5.043651,"marketCap":561334272},{"date":"2025-07-18","current":-6.795718,"twenty":-14.077333,"median":-9.430989,"eighty":-5.078884,"marketCap":541625526},{"date":"2025-07-25","current":-7.610838,"twenty":-13.779001,"median":-9.362262,"eighty":-5.090926,"marketCap":606591391},{"date":"2025-08-01","current":-6.57591,"twenty":-13.6976,"median":-9.168805,"eighty":-5.092192,"marketCap":524106641},{"date":"2025-08-08","current":-6.368661,"twenty":-13.694662,"median":-9.054259,"eighty":-5.099519,"marketCap":562429202},{"date":"2025-08-15","current":-6.17446,"twenty":-13.609134,"median":-8.982986,"eighty":-5.10525,"marketCap":545278924},{"date":"2025-08-22","current":-6.170327,"twenty":-13.473486,"median":-8.4968,"eighty":-5.115317,"marketCap":544913945},{"date":"2025-08-29","current":-6.943168,"twenty":-13.38251,"median":-8.407708,"eighty":-5.122916,"marketCap":613165056},{"date":"2025-09-05","current":-6.343907,"twenty":-13.171889,"median":-8.282979,"eighty":-5.126995,"marketCap":560243072},{"date":"2025-09-12","current":-9.588184,"twenty":-13.020376,"median":-8.364435,"eighty":-5.143059,"marketCap":846751744},{"date":"2025-09-19","current":-14.281097,"twenty":-13.398113,"median":-8.486618,"eighty":-5.165131,"marketCap":1261192245},{"date":"2025-09-26","current":-13.038354,"twenty":-13.650327,"median":-8.934622,"eighty":-5.176938,"marketCap":1151443158},{"date":"2025-10-03","current":-14.902468,"twenty":-13.718742,"median":-9.051713,"eighty":-5.195691,"marketCap":1316066789},{"date":"2025-10-10","current":-13.962579,"twenty":-13.896787,"median":-9.158623,"eighty":-5.223161,"marketCap":1233063277},{"date":"2025-10-17","current":-12.986138,"twenty":-13.856058,"median":-9.228454,"eighty":-5.262092,"marketCap":1146831851},{"date":"2025-10-24","current":-13.675391,"twenty":-13.856058,"median":-9.397898,"eighty":-5.294604,"marketCap":1207701093},{"date":"2025-10-31","current":-14.035682,"twenty":-13.934383,"median":-9.502263,"eighty":-5.303959,"marketCap":1239519106},{"date":"2025-11-07","current":-11.969573,"twenty":-13.970933,"median":-9.588184,"eighty":-5.319746,"marketCap":1169427252},{"date":"2025-11-14","current":-12.034803,"twenty":-13.934383,"median":-9.698265,"eighty":-5.33408,"marketCap":1175800274},{"date":"2025-11-21","current":-13.098276,"twenty":-13.915585,"median":-9.917175,"eighty":-5.342242,"marketCap":1279701555},{"date":"2025-11-28","current":-14.493474,"twenty":-13.931568,"median":-10.309179,"eighty":-5.356195,"marketCap":1416012409},{"date":"2025-12-05","current":-14.000764,"twenty":-13.954437,"median":-10.426271,"eighty":-5.376155,"marketCap":1367874660},{"date":"2025-12-12","current":-14.039791,"twenty":-13.99491,"median":-10.604143,"eighty":-5.393122,"marketCap":1371687551},{"date":"2025-12-19","current":-14.459326,"twenty":-14.050476,"median":-10.719003,"eighty":-5.431972,"marketCap":1412676130},{"date":"2025-12-26","current":-15.088628,"twenty":-14.119227,"median":-10.841851,"eighty":-5.476848,"marketCap":1474158998},{"date":"2026-01-02","current":-14.800808,"twenty":-14.281097,"median":-10.940782,"eighty":-5.513507,"marketCap":1446038926},{"date":"2026-01-09","current":-13.81051,"twenty":-14.281097,"median":-10.976093,"eighty":-5.513507,"marketCap":1349286816},{"date":"2026-01-16","current":-13.103154,"twenty":-14.237527,"median":-11.048158,"eighty":-5.513507,"marketCap":1280178166},{"date":"2026-01-23","current":-13.620256,"twenty":-14.172521,"median":-11.156822,"eighty":-5.535473,"marketCap":1330698972},{"date":"2026-01-30","current":-13.049493,"twenty":-14.13499,"median":-11.312246,"eighty":-5.592253,"marketCap":1274935441},{"date":"2026-02-06","current":-12.464095,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"marketCap":1217742075}],"updateTime":1770712848370},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1131033553","title":"Rapport Therapeutics计划于2027年上半年启动RAP-219治疗PGTCs的三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1131033553","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131033553?lang=zh_cn&edition=fundamental","pubTime":"2026-01-07 20:08","pubTimestamp":1767787738,"startTime":"0","endTime":"0","summary":"生物制药公司Rapport Therapeutics, Inc.近日披露重要研发进展,宣布将于2027年上半年正式启动其核心候选药物RAP-219针对原发性全身性强直阵挛发作的三期临床试验。这一关键性临床阶段的启动,标志着该药物在癫痫治疗领域的开发迈入决定性阶段。业界关注到,RAP-219作为一种创新疗法,其临床进展对满足PGTCs患者的未竟医疗需求具有重要意义。此次三期试验的启动计划,不仅体现了Rapport Therapeutics在神经科学领域的研发实力,也可能为癫痫治疗格局带来新的变革。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2584923536","title":"BUZZ--美国股票走势-星座能源、威廉姆斯-索诺玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2584923536","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584923536?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 23:59","pubTimestamp":1763567988,"startTime":"0","endTime":"0","summary":"标普500指数.SPX上涨0.90%,报6,676.77点;纳斯达克综合指数.IXIC上涨1.48%,报22,763.88点。nL6N3WV0P7 ** Agios Pharmaceuticals Inc AGIO.O:BUZZ - 因镰状细胞药物未能达到疼痛危机目标而下挫。nL6N3WV0QE ** TJX Companies Inc TJX.N:BUZZ - TJ Maxx 母公司 TJX 上调年度预期后股价上涨 nL6N3WV0R7 ** Sociedad Quimica y Minera de Chile SA SQM.N:BUZZ - 因业绩和预测看涨而上扬,提振锂业同行 nL6N3W","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV1FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DLB","XOM","TJX","ON","CEVA","AVDL","CURB","DASH","U","WSM","NNE","NNOX","CVX","PRAX","SCCO","DOW","RDW","ONCY","OWL","ALZN","FCX","COP","GLBE","GEV","LYB","RAPP","DY","CEG","SION","GLAD","H","VTVT","HL","ZION","MAR","NUVL","LOW","AGIO","SEMR","CDE","TGT"],"gpt_icon":1},{"id":"2584942096","title":"BUZZ--美国股票走势-Lowe's, TJX Companies, Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584942096","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584942096?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 22:25","pubTimestamp":1763562342,"startTime":"0","endTime":"0","summary":".N** 杜比实验室公司DLB.N:BUZZ - 节假日期间的季度业绩预期不及预期,股价下跌。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4T3WV18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","ALZN","BHP.AU","NVD3.UK","CURB","CARV","NVIW.SI","ON","PRAX","NVD2.UK","NVD","NVDS.UK","SEMR","RAPP","HL","DASH","SNVD.UK","ZION","AU","2NVD.UK","TGT","RIO.UK","GEV","LYB","VTVT","GLAD","SION","TJX","CDE","CEVA","LOW","DOW","DLB","PPL","RIO.AU","AVDL","SCCO","FCX","ALKS","NVDD"],"gpt_icon":1},{"id":"2584594209","title":"BUZZ--美国股票走势-Lowe's, TJX Companies, Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2584594209","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584594209?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 22:25","pubTimestamp":1763562342,"startTime":"0","endTime":"0","summary":".N** 杜比实验室公司DLB.N:BUZZ - 节假日期间的季度业绩预期不及预期,股价下跌。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV18U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DLB","NVDU","NVD","NVDD","TJX","ON","BHP.AU","CEVA","AVDL","CURB","CARV","DASH","NVD2.UK","RIO.AU","NVDX","PRAX","SCCO","AU","DOW","NVD3.UK","ALZN","FCX","GEV","LYB","RAPP","SION","ALKS","GLAD","NVDS","VTVT","HL","ZION","PPL","RIO.UK","LOW","AGIO","SEMR","CDE","TGT"],"gpt_icon":1},{"id":"2584100459","title":"BUZZ-BTIG 转而看好生物技术行业,认为 2026 年将是 \"辉煌的一年","url":"https://stock-news.laohu8.com/highlight/detail?id=2584100459","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584100459?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 19:02","pubTimestamp":1763550138,"startTime":"0","endTime":"0","summary":"BUZZ-BTIG 转而看好生物技术行业,认为 2026 年将是 \"辉煌的一年11月19日 - ** BTIG 表示,随着利率下调和并购活动的增加,2025 年中小市值生物技术股将迎来利好因素** 监管效率的提高可能是 2026 年生物技术行业的主要利好因素--BTIG** 我们认为 2026 年将是辉煌的一年。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV0U7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP","LU0889565916.HKD","VTVT","PRAX","SION","BK4139","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2584918469","title":"美国研究综述-安进、Crowdstrike、美光科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2584918469","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584918469?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 15:17","pubTimestamp":1763536643,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Crowdstrike、美光科技路透11月19日 - 华尔街证券分析师周三调整了对安进公司、Crowdstrike 和美光科技等几家美国上市公司的评级和目标价。要闻 * 安进公司AMGN.O:汇丰银行将目标价从343美元上调至381美元 * Crowdstrike CRWD.O:杰富瑞将目标价从515美元上调至600美元 * 美光科技MU.O:TD Cowen将目标价从200美元上调至275美元 * Praxis Precision Medicines Inc PRAX.O:BTIG给予买入评级 * Universal Health Services Inc UHS.N:摩根大通将目标价从195美元上调至240美元以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4S3WV0H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","AMGN","LU1116320737.USD","VTVT","WCC","BRBR","PRAX","RAPP","RARE","TERN","FCX","LU0823414478.USD","MBI","LU0819121731.USD","KNTK","ZYME","LU0417516738.SGD","LU1941712348.USD","BK4514","NUVB","LU0287142896.SGD","89888","UHS","INCY","PCVX","LU0128525929.USD","CRWD","DASH","IPAR","SION","ZION","LGIH","ARWR","LU1934455194.USD","ENR","COTY","OLMA","IE00BWXC8680.SGD","SG9999014674.SGD","MU","LU0353189763.USD","BK1609","LU0029864427.USD","DKS","HD","HK0000306685.HKD"],"gpt_icon":1},{"id":"1117807206","title":"Rapport Therapeutics:Rap-219 第二阶段临床试验进展顺利,预计2027年上半年公布主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1117807206","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117807206?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 20:22","pubTimestamp":1762431766,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics:Rap-219 第二阶段临床试验进展顺利,预计2027年上半年公布主要结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2581214792","title":"生物科技股复苏:四大因素推动行业上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2581214792","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581214792?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 16:52","pubTimestamp":1762246369,"startTime":"0","endTime":"0","summary":"经过四年的低迷期,生物科技行业正在迎来复苏,多个因素推动其股价回升。这种单日上涨的幅度吸引了投资者的注意,进一步支持了生物科技股的上涨。这使得整个行业更容易继续上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104173307a48768cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104173307a48768cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XBI","SG9999015986.USD","AMGN","IE0002141913.USD","LU1718418525.SGD","LU1983299246.USD","QURE","RAPP","BMY","IE00BBT3K403.USD","LU2552382215.SGD","SG9999013999.USD","BK4585","LU0985481810.HKD","LU1623119135.USD","ASND","LU2237443382.USD","NBIX","ABBV","LU0128525929.USD","LU2360106947.USD","LU0203202063.USD","LU2129689605.HKD","LU0122379950.USD","MEDI","LU0203201768.USD","LU0203347892.USD","SG9999011175.SGD","LU2602419157.SGD","BK4009","MBX","ALKS","LU0234570918.USD","BBIO","LU1934455194.USD","LU2552382058.USD","MDGL","ALNY","LU1551013342.USD","LU2211815571.USD","BK4007","HHS","BK4548","LU0237698245.USD","PRAX","LU0321505868.SGD","ARGX","LU2324357040.USD"],"gpt_icon":1},{"id":"2566952752","title":"美国研究综述-Chewy、Phillips 66、Vimeo","url":"https://stock-news.laohu8.com/highlight/detail?id=2566952752","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566952752?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 15:57","pubTimestamp":1757577462,"startTime":"0","endTime":"0","summary":"美国研究综述-Chewy、Phillips 66、Vimeo路透社9月11日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Chewy、Phillips 66 和 Vimeo。要闻* Chewy公司CHWY.N:摩根大通将目标价从47美元下调至45美元 * Phillips 66 PSX.N:Piper Sandler将目标价从144美元上调至154美元 * Vimeo Inc VMEO.O:Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3T3UY0HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","LU0757428866.USD","PARR","IE00B3CCJ963.GBP","LU0266512127.USD","BK4221","WK","RAPP","DK","IE00BGHQF524.EUR","BK4138","LU1169590202.USD","VMEO","CASY","LU0208291251.USD","TPR","LU0130517989.USD","LU0566484027.USD","LU1267930227.SGD","BK4139","MPC","WY","IE00B3T34201.USD","BK4084","LU1169589451.USD","BK4113","BK4202","LU0130102774.USD","LU0310800965.SGD","LU0368265418.SGD","LU0980610538.SGD","DINO","MNSH","LU1941712348.USD","FROG","LU0345780950.USD","IE00B2Q91V27.USD","LU1941712264.USD","BK4200","PSX","CHWY","BK4023","BK4585","IE0009354923.USD","RBRK","PBF","LU1559883803.SGD","VLO","CAMP"],"gpt_icon":0},{"id":"2566757952","title":"美国研究综述-Chewy、Phillips 66、Vimeo","url":"https://stock-news.laohu8.com/highlight/detail?id=2566757952","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566757952?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 15:57","pubTimestamp":1757577462,"startTime":"0","endTime":"0","summary":"美国研究综述-Chewy、Phillips 66、Vimeo路透社9月11日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Chewy、Phillips 66 和 Vimeo。要闻* Chewy公司CHWY.N:摩根大通将目标价从47美元下调至45美元 * Phillips 66 PSX.N:Piper Sandler将目标价从144美元上调至154美元 * Vimeo Inc VMEO.O:Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3S3UY0HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","LU0757428866.USD","PARR","IE00B3CCJ963.GBP","LU0266512127.USD","BK4221","WK","RAPP","DK","IE00BGHQF524.EUR","BK4138","LU1169590202.USD","VMEO","CASY","LU0208291251.USD","TPR","LU0130517989.USD","LU0566484027.USD","LU1267930227.SGD","BK4139","MPC","WY","IE00B3T34201.USD","BK4084","LU1169589451.USD","BK4113","BK4202","LU0130102774.USD","LU0310800965.SGD","LU0368265418.SGD","LU0980610538.SGD","DINO","MNSH","LU1941712348.USD","FROG","LU0345780950.USD","IE00B2Q91V27.USD","LU1941712264.USD","BK4200","PSX","CHWY","BK4023","BK4585","IE0009354923.USD","RBRK","PBF","LU1559883803.SGD","VLO","CAMP"],"gpt_icon":0},{"id":"2566988061","title":"美股周三早盘专注于中枢神经系统(CNS)疾病创新疗法研发的生物制药公司Rapport Therapeutics股价重挫此","url":"https://stock-news.laohu8.com/highlight/detail?id=2566988061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566988061?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 23:46","pubTimestamp":1757519183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RAPP","BK4539","BK4139","CNS","BK4135","LENZ","BK4007"],"gpt_icon":0},{"id":"2566600190","title":"生物制药公司Rapport重挫18.8%,此前完成2.5亿美元的公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2566600190","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566600190?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 22:54","pubTimestamp":1757516040,"startTime":"0","endTime":"0","summary":"美股周三早盘,专注于中枢神经系统(CNS)疾病创新疗法研发的生物制药公司Rapport Therapeutics(RAPP)股价重挫18.8%,此前该公司以每股26美元的价格完成2.5亿美元的公开发行。\n 此次发行预计将于2025年9月11日完成,所筹资金将用于支持公司的增长计划。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-09-10/doc-infpzray3944272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RAPP","BK4007","BK4135","CNS"],"gpt_icon":0},{"id":"2566677768","title":"BUZZ-Rapport Therapeutics 募资 2.5 亿美元后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2566677768","media":"路透中文","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566677768?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 18:29","pubTimestamp":1757500140,"startTime":"0","endTime":"0","summary":"** Rapport TherapeuticsRAPP.O在后续发行定价后,股价在收盘前下跌 2.5%,至 27.34 美元。** 该公司在周二晚些时候宣布, ~960万股,发行价为26美元,募集资金总额为2.5亿美元。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nL3T3UX0QH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","LU1778281490.HKD","IE0004086264.USD","JNJ","IE00B1BXHZ80.USD","LU1032466523.USD","IE00B19Z3581.USD","LU2430703095.HKD","BK4007","LU0098860793.USD","LU0432979614.USD","LU1162221912.USD","LU2471134523.USD","LU1267930813.SGD","LU0058720904.USD","IE00BBT3K403.USD","LU0640476718.USD","LU0234572021.USD","LU0234570918.USD","LU1894683264.USD","LU1791807156.HKD","LU2237443549.SGD","LU1894683348.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","LU1066051225.USD","LU1732799900.SGD","LU0345769631.USD","IE00BGHQF631.EUR","RAPP","LU2089984988.USD","BK4581","SF","LU0061475181.USD","LU2471134952.CNY","LU0795875086.SGD","IE00BFTCPJ56.SGD","LU1868836591.USD","BK4534","LU1057294990.SGD","IE00B4R5TH58.HKD","BK4532","LU2237438978.USD","LU1221951046.USD","IE00B42XCP33.USD","BK4592","LU0070217475.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"1160286321","title":"Rapport Therapeutics Inc.按每股26.00美元价格公开发行960万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1160286321","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160286321?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 09:19","pubTimestamp":1757467151,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Inc.宣布以每股26.00美元的价格公开发行960万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2566866487","title":"美国研究综述-IQVIA Holdings、Reliance、United Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2566866487","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566866487?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 15:29","pubTimestamp":1757402943,"startTime":"0","endTime":"0","summary":"美国研究综述-IQVIA Holdings、Reliance、United Therapeutics路透社9月9日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 IQVIA Holdings、Reliance 和 United Therapeutics。要点 * IQVIA Holdings Inc IQV.N:杰富瑞将其评级从 \"持有 \"上调至 \"买入 * 信实公司RS.N:摩根大通给予增持评级 * United Therapeutics Corp UTHR.O:摩根大通将目标价从345美元上调至450美元以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL3S3UW0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4100","IE00B19Z3581.USD","CRL","LU0528227936.USD","LU0882574055.USD","PIPR","RAPP","LU1064131342.USD","CEG","ELF","BMI","TKO","IE0004445239.USD","BK4212","IE00BLSP4239.USD","IQV","LU0158827948.USD","LU2089283258.USD","BK4007","SRPT","LU2098885051.SGD","WING","FDS","NGS","UTHR","LU1951198990.SGD","FTRE","RS","SGXZ81514606.USD","MEDP","CMG","TASK","LU2095319765.USD","SATS","BAC","INSM","LU1894683348.USD","HSY","BK4089","SEE","APEI","LU0047713382.USD","EMN","LU0130102774.USD","EPAM","LU1861217088.USD","LU1988902786.USD"],"gpt_icon":1},{"id":"2566637280","title":"Pmv Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566637280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566637280?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 23:46","pubTimestamp":1757346380,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日23时46分,Pmv Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.14%。截至发稿,该股报1.39美元/股,成交量37.4323万股,换手率0.71%,振幅4.45%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。其相关个股中,Rapport Therapeutics, Inc.、Yd Bio Ltd C/Wts 28/08/2030、Acrivon Therapeutics, Inc.涨幅较大,Cdt Equity Inc.、Genprex, Inc.、Indaptus Therapeutics, Inc.较为活跃,换手率分别为849.92%、458.29%、74.80%,振幅较大的相关个股有Rapport Therapeutics, Inc.、Genprex, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为105.96%、73.86%、47.89%。Pmv Pharmaceuticals, Inc.公司简介:PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908234621a4bbb4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908234621a4bbb4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"1127369274","title":"异动解读 | 癫痫药物临床试验成功,Rapport Therapeutics盘前大涨171.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127369274","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127369274?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 18:46","pubTimestamp":1757328398,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc.今日盘前股价大涨171.59%,引发市场广泛关注。这一显著涨幅主要源于该公司宣布其实验性癫痫药物RAP-219在中期临床试验中取得积极结果。根据公司公布的数据,RAP-219在针对难以治疗的局灶性癫痫发作成人患者的2a期临床试验中表现出色。Rapport Therapeutics表示,计划在2025年第四季度与美国食品药品监督管理局举行2期试验结束会议,并有意在2026年第三季度启动两项后期研究。考虑到该公司此前年内股价累计下跌19.5%,这次利好消息无疑为投资者注入了新的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RAPP"],"gpt_icon":1},{"id":"1191517947","title":"Rapport Therapeutics公布局灶性癫痫发作试验积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1191517947","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191517947?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 18:42","pubTimestamp":1757328127,"startTime":"0","endTime":"0","summary":"9月8日 - Rapport Therapeutics Inc.宣布其RAP-219药物在局灶性癫痫发作患者中的2A期临床试验取得积极的顶线结果。\n试验达到主要终点,RAP-219耐受性良好。\n患者癫痫发作减少77.8%,24%的患者实现无癫痫发作状态。\nRAP-219耐受性良好,不良事件轻微。\n公司计划在2025年第四季度与美国食品药品监督管理局(FDA)举行2期试验结束会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2565668887","title":"BUZZ-癫痫药物在中期试验中达到主要目标,Rapport Therapeutics 公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2565668887","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565668887?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 18:27","pubTimestamp":1757327265,"startTime":"0","endTime":"0","summary":"** Rapport公司表示,计划在今年晚些时候与美国监管机构会面,并在2026年第三季度启动两项后期研究。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL3T3UV0PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"1101085848","title":"Rapport Therapeutics股价盘前大涨75.5%,局灶性癫痫发作治疗药物中期试验数据表现积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1101085848","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101085848?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 18:10","pubTimestamp":1757326214,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics股价在盘前交易中暴涨75.5%,该公司公布的局灶性癫痫发作治疗药物中期试验数据表现良好,推动股价大幅上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}